{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "58552-149",
      "generic_name": "Dextromethorphan HBr",
      "labeler_name": "Gil Pharmaceutical Corp",
      "brand_name": "GILTUSS DIABETIC DM",
      "active_ingredients": [
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "30 mg/10mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "58552-149-04",
          "description": "1 BOTTLE in 1 CARTON (58552-149-04)  / 118 mL in 1 BOTTLE",
          "marketing_start_date": "20230809",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Gil Pharmaceutical Corp"
        ],
        "rxcui": [
          "1090496"
        ],
        "spl_set_id": [
          "bd367ce1-996b-45bc-865e-b6aafe0ea7b0"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "9D2RTI9KYH"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "SOLUTION",
      "spl_id": "40b94d7e-722e-6dce-e063-6394a90a2e10",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20230809",
      "product_id": "58552-149_40b94d7e-722e-6dce-e063-6394a90a2e10",
      "application_number": "M012",
      "brand_name_base": "GILTUSS DIABETIC DM",
      "pharm_class": [
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]"
      ]
    }
  ]
}